RMTI · Insider Trading
Rockwell Medical, Inc. (DE) Common Stock
Every open-market purchase and sale reported by RMTI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Mark Strobeck | President and CEO | Sell | −1,000 | −$8.42K |
| 2026-07-06 | Allen Nissenson | Director | A | +9,633 | — |
| 2026-07-06 | Timothy Chole | SVP and CCO | A | +15,000 | — |
| 2026-07-06 | Joseph H Dawson | Director | A | +9,633 | — |
| 2026-07-06 | Megan C. Timmins | EVP, CLO & Secretary | A | +15,000 | — |
| 2026-07-06 | John G Cooper | Director | A | +9,633 | — |
| 2026-07-06 | Joan Lau | Director | A | +9,633 | — |
| 2026-07-06 | Mark Strobeck | President and CEO | A | +30,000 | — |
| 2026-07-06 | Heather Hunter | Chief Operating Officer | A | +15,000 | — |
| 2026-07-06 | Robert S Radie | Director | A | +9,633 | — |
| 2026-07-06 | Jesse Neri | SVP and CFO | A | +15,000 | — |
| 2026-04-17 | Jesse Neri | SVP, FINANCE AND CFO | A | +97,500 deriv. | — |
| 2026-04-17 | Mark Strobeck | President and CEO | A | +352,000 deriv. | — |
| 2026-04-17 | Timothy Chole | SVP, Chief Commercial Officer | A | +85,000 deriv. | — |
| 2026-04-17 | Megan C. Timmins | EVP, CLO and Secretary | A | +97,500 deriv. | — |
| 2026-03-16 | Jesse Neri | SVP and CFO | F | −2,444 | −$2.20K |
| 2026-03-16 | Megan C. Timmins | See Remarks | F | −3,667 | −$3.30K |
| 2026-03-16 | Mark Strobeck | President and CEO | F | −7,333 | −$6.60K |
| 2026-03-16 | Timothy Chole | SVP and CCO | F | −2,444 | −$2.20K |
| 2026-03-16 | Heather Hunter | Chief Operating Officer | F | −2,444 | −$2.20K |
| 2026-01-05 | Jesse Neri | SVP and CFO | Sell | −886 | −$740 |
| 2026-01-05 | Heather Hunter | Chief Operating Officer | Sell | −2,868 | −$2.40K |
| 2025-11-20 | Joseph H Dawson | Director | A | +25,000 | — |
| 2025-11-18 | John G Cooper | Director | Sell | −5,079 | −$4.42K |
| 2025-10-08 | Heather Hunter | SVP, Chief Operating Officer | Sell | −2,868 | −$3.41K |
| 2025-10-01 | Timothy Chole | SVP and CCO | Sell | −2,868 | −$3.41K |
| 2025-10-01 | Jesse Neri | SVP and CFO | Sell | −886 | −$1.05K |
| 2025-10-01 | Mark Strobeck | President and CEO | Sell | −6,926 | −$8.24K |
| 2025-07-03 | Jesse Neri | SVP and CFO | Sell | −886 | −$727 |
| 2025-07-03 | Timothy Chole | SVP and CCO | Sell | −2,868 | −$2.35K |
| 2025-07-03 | Mark Strobeck | President and CEO | Sell | −6,926 | −$5.68K |
| 2025-07-02 | Jesse Neri | SVP and CFO | Sell | −886 | −$727 |
| 2025-07-02 | Mark Strobeck | President and CEO | Sell | −6,926 | −$5.68K |
| 2025-07-02 | Timothy Chole | SVP and CCO | Sell | −2,868 | −$2.35K |
| 2025-05-21 | Allen Nissenson | Director | A | +50,000 | — |
| 2025-05-21 | Andrea Heslin Smiley | Director | A | +50,000 | — |
| 2025-05-21 | Robert S Radie | Director | A | +50,000 | — |
| 2025-05-21 | Joan Lau | Director | A | +50,000 | — |
| 2025-05-21 | John G Cooper | Director | A | +50,000 | — |
| 2025-05-21 | Megan C. Timmins | EVP, CLO and Secretary | A | +97,500 | — |
| 2025-05-21 | Timothy Chole | SVP, Chief Commercial Officer | A | +85,000 | — |
| 2025-05-21 | Mark Strobeck | President and CEO | A | +220,000 | — |
| 2025-05-21 | Mark H Ravich | Director | A | +50,000 | — |
| 2025-05-21 | Jesse Neri | SVP, FINANCE AND CFO | A | +97,500 | — |
| 2025-04-15 | Irrevocable Larson Family Investment Trust | 10%+ Owner | Buy | +87,500 | +$94.02K |
| 2025-04-02 | Mark Strobeck | President and CEO | Sell | −6,926 | −$7.48K |
| 2025-04-02 | Timothy Chole | SVP, Chief Commercial Officer | Sell | −2,868 | −$3.10K |
| 2025-04-02 | Jesse Neri | SVP, FINANCE AND CFO | Sell | −886 | −$975 |
| 2025-03-18 | Mark Strobeck | President and CEO | F | −13,434 | −$23.26K |
| 2025-03-18 | Megan C. Timmins | EVP, CLO and Secretary | F | −6,803 | −$11.78K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Irrevocable Larson Family Investment Trust | 10%+ Owner | 349,900 | $2.45M |
| Mark Strobeck | President and CEO | 61,349 | $429.44K |
| Megan C. Timmins | EVP, CLO & Secretary | 31,240 | $218.68K |
| Heather Hunter | Chief Operating Officer | 28,007 | $196.05K |
| Timothy Chole | SVP and CCO | 27,285 | $191.00K |
| Jesse Neri | SVP and CFO | 27,239 | $190.67K |
| Robert S Radie | Director | 23,985 | $167.90K |
| Allen Nissenson | Director | 23,892 | $167.24K |
| John G Cooper | Director | 23,670 | $165.69K |
| Joan Lau | Director | 20,944 | $146.61K |
| Mark H Ravich | Director | 14,965 | $104.75K |
| Andrea Heslin Smiley | Director | 14,206 | $99.44K |
| Joseph H Dawson | Director | 12,133 | $84.93K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RMTI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.